Evidence map›Paper›PMID 26928365›Full record

ArticleScientific reports2016

MiR-1180 promotes apoptotic resistance to human hepatocellular carcinoma via activation of NF-κB signaling pathway.

Guosheng Tan, Linwei Wu, Jinfu Tan, Bing Zhang, William Chi-shing Tai, Shiqiu Xiong, Wei Chen, Jianyong Yang, Heping Li

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Guosheng TanDepartment of Interventional Radiology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, P.R. China.
Linwei WuOrgan Transplantation Center, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
Jinfu TanDepartment of Anorectal &Hernial Surgery, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, P.R. China.
Bing ZhangDepartment of Nuclear Medicine, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, P.R. China.
William Chi-shing TaiCentre for Cancer and Inflammation Research, School of Chinese Medicine, Hong Kong Baptist University. Kowloon Tong, Hong Kong, S.A.R., P.R. China.
Shiqiu XiongDepartment of Biochemistry, University of Leicester, Leicester, UK.
Wei ChenDepartment of Interventional Radiology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, P.R. China.
Jianyong YangDepartment of Interventional Radiology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, P.R. China.
Heping LiDepartment of Interventional Radiology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, P.R. China.
The First Affiliated Hospital, Sun Yat-sen University · CNSun Yat-sen University · CNHong Kong Baptist University · HKUniversity of Leicester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Apoptosis resistance in human hepatocellular carcinoma (HCC) is a significant factor in carcinogenesis. Therefore, understanding the molecular mechanisms involved in apoptosis resistance is crucial for developing anticancer therapies. Importantly, small non-coding microRNAs (miRNAs) have been reported as key biomarkers for detecting tumour onset and progression. In the present study, we demonstrate that miR-1180 is upregulated in HCC. Ectopic expression of miR-1180 has an anti-apoptotic effect in HCC, while miR-1180 inhibition increases cell apoptosis, both in vitro and in vivo. Moreover, our results show that miR-1180 directly targets key inhibitors of the nuclear factor (NF)-κB signaling pathway (i.e., OTUD7B and TNIP2) and the pro-apoptotic Bcl-2 associated death promoter (BAD) protein by post-transcriptional downregulation. Therefore, the anti-apoptotic function of miR-1180 in HCC may occur through NF-κB pathway activation via downregulation of its negative regulators. In conclusion, our study reveals the critical role of miR-1180 during apoptosis resistance in HCC.

Indexed as

Adaptor Proteins, Signal TransducingApoptosisbcl-Associated Death ProteinBiomarkers, TumorCarcinogenesisCarcinoma, HepatocellularCell Line, TumorDown-RegulationEndopeptidasesGene Expression Regulation, NeoplasticHumansLiver NeoplasmsMicroRNAsNF-kappa BSignal TransductionAdaptor Proteins, Signal TransducingBAD protein, humanbcl-Associated Death ProteinBiomarkers, TumorEndopeptidasesMicroRNAsMIRN1180 microRNA, humanNF-kappa BOTUD7B protein, humanTNIP2 protein, human

Identifiers

PMID26928365
PMCPMC4772113
OpenAlexW2329300933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.